BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 25665999)

  • 1. Significant simultaneous changes in serum CA19-9 and CA125 due to prolonged torsion of mature cystic teratoma of the ovary.
    Suh DS; Moon SH; Kim SC; Joo JK; Park WY; Kim KH
    World J Surg Oncol; 2014 Nov; 12():353. PubMed ID: 25416055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR diagnosis of SCC arising within ovarian cystic teratomas: analysis of mural nodule characteristics.
    Fukuzawa T; Ohya A; Tanaka M; Shimizu M; Kobayashi K; Matsushita T; Watanabe T; Kobara H; Fujinaga Y
    Abdom Radiol (NY); 2024 Apr; 49(4):1264-1274. PubMed ID: 38393356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal tract-like muscular walls in ovarian mature cystic teratomas: A histopathological study.
    Matsukuma S; Takahashi O; Utsumi Y; Miyai K; Takeo H
    Mol Clin Oncol; 2017 Oct; 7(4):642-648. PubMed ID: 29046797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Types and Frequency of Neural Elements in Mature Ovarian Teratomas: An 11-Year Study from Rural India.
    Kumar R; Dayal S; Krishna M
    J Microsc Ultrastruct; 2022; 10(4):154-158. PubMed ID: 36687327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is There a Role of Elevated CA 19-9 Levels in the Evaluation of Clinical Characteristics of Mature Cystic Ovarian Teratomas? A Systematic Review and Meta-analysis.
    Prodromidou A; Pandraklakis A; Loutradis D; Haidopoulos D
    Cureus; 2019 Dec; 11(12):e6342. PubMed ID: 31938630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging in gynecological disease (24): clinical and ultrasound characteristics of ovarian mature cystic teratomas.
    Heremans R; Valentin L; Sladkevicius P; Timmerman S; Moro F; Van Holsbeke C; Epstein E; Testa AC; Timmerman D; Froyman W
    Ultrasound Obstet Gynecol; 2022 Oct; 60(4):549-558. PubMed ID: 35316568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers in mature cystic teratomas of the ovary.
    Ustunyurt E; Gungor T; Iskender C; Ustunyurt BO; Bilge U; Mollamahmutoglu L
    Arch Gynecol Obstet; 2009 Feb; 279(2):145-7. PubMed ID: 18506458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do high levels of CA 19-9 in women with mature cystic teratomas of the ovary warrant further evaluation?
    Ugur MG; Ozturk E; Balat O; Dikensoy E; Teke S; Aydin A
    Eur J Gynaecol Oncol; 2012; 33(2):207-10. PubMed ID: 22611965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma.
    Cho HY; Kim K; Jeon YT; Kim YB; No JH
    Med Sci Monit; 2013 Mar; 19():230-5. PubMed ID: 23539074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
    Kataoka T; Watanabe Y; Hoshiai H
    J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-stratified analysis of tumor markers and tumor characteristics in adolescents and young women with mature cystic teratoma.
    Yesilyurt H; Seckin B; Aktulay A; Ozyer S
    J Chin Med Assoc; 2018 Jun; 81(6):499-504. PubMed ID: 28826726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mature cystic teratomas: relationship between histopathological contents and clinical features.
    Cakmak B; Nacar M; Ozsoy Z; Aliyev N; Koseoglu D
    Niger J Clin Pract; 2015; 18(2):236-9. PubMed ID: 25665999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA 19-9 in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.
    Sagi-Dain L; Lavie O; Auslander R; Sagi S
    Int J Biol Markers; 2015 Jul; 30(3):e333-40. PubMed ID: 25704505
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.